Frans Gustaf Wuite
Director/Board Member at HERANTIS PHARMA OYJ
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Antti Vuolanto | M | - |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | 13 years |
| Henri Juhani Huttunen | M | - | 16 years | |
| Toni Leinonen | M | - |
Nukute Oy
 Nukute Oy Medical SpecialtiesHealth Technology Nukute Oy is a Finnish company that aims to improve the diagnosis of sleep apnea. Nukute is based in Oulu, FI. The company provides a Collare system that has been evaluated for its usability and clinical performance. The company was founded by Tuukka Visuri and Toni Leinonen, with Toni Leinonen serving as the CEO since incorporation. | - |
| Timo Ilari Veromaa | M | 64 | 12 years | |
| Tuukka Visuri | M | - |
Nukute Oy
Nukute Oy Medical SpecialtiesHealth Technology Nukute Oy is a Finnish company that aims to improve the diagnosis of sleep apnea. Nukute is based in Oulu, FI. The company provides a Collare system that has been evaluated for its usability and clinical performance. The company was founded by Tuukka Visuri and Toni Leinonen, with Toni Leinonen serving as the CEO since incorporation. | - |
| Mats Johan Peter Thorén | M | 53 | 4 years | |
| Hilde Furberg | F | 65 | 3 years | |
| Timo Niinikoski | M | - |
Nukute Oy
Nukute Oy Medical SpecialtiesHealth Technology Nukute Oy is a Finnish company that aims to improve the diagnosis of sleep apnea. Nukute is based in Oulu, FI. The company provides a Collare system that has been evaluated for its usability and clinical performance. The company was founded by Tuukka Visuri and Toni Leinonen, with Toni Leinonen serving as the CEO since incorporation. | - |
| Timo Tapio Laitinen | M | 71 |
Nukute Oy
Nukute Oy Medical SpecialtiesHealth Technology Nukute Oy is a Finnish company that aims to improve the diagnosis of sleep apnea. Nukute is based in Oulu, FI. The company provides a Collare system that has been evaluated for its usability and clinical performance. The company was founded by Tuukka Visuri and Toni Leinonen, with Toni Leinonen serving as the CEO since incorporation. | - |
| Aki Pellervo Prihti | M | 53 | 10 years | |
| Timo Tapio Hildén | M | 65 |
Nukute Oy
Nukute Oy Medical SpecialtiesHealth Technology Nukute Oy is a Finnish company that aims to improve the diagnosis of sleep apnea. Nukute is based in Oulu, FI. The company provides a Collare system that has been evaluated for its usability and clinical performance. The company was founded by Tuukka Visuri and Toni Leinonen, with Toni Leinonen serving as the CEO since incorporation. | 3 years |
| Tone Kvåle | F | 55 | 4 years | |
| Jonas Karl Hansson | M | 50 |
HealthCap VII GP SA
| - |
| Sari Pesonen | M | - |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | 11 years |
| Johan S. Johannes Gullichsen | M | 60 |
Nukute Oy
Nukute Oy Medical SpecialtiesHealth Technology Nukute Oy is a Finnish company that aims to improve the diagnosis of sleep apnea. Nukute is based in Oulu, FI. The company provides a Collare system that has been evaluated for its usability and clinical performance. The company was founded by Tuukka Visuri and Toni Leinonen, with Toni Leinonen serving as the CEO since incorporation. | - |
| Pekka Virtanen | M | - |
Nukute Oy
Nukute Oy Medical SpecialtiesHealth Technology Nukute Oy is a Finnish company that aims to improve the diagnosis of sleep apnea. Nukute is based in Oulu, FI. The company provides a Collare system that has been evaluated for its usability and clinical performance. The company was founded by Tuukka Visuri and Toni Leinonen, with Toni Leinonen serving as the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pekka Ilmari Simula | M | 50 |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | 11 years |
| Craig Cook | M | 57 | - | |
| Frederick J. Hamble | M | - |
Warren Pharmaceuticals, Inc.
 Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | - |
| Geert H. Graaf | M | - |
University of Groningen
| 8 years |
| James Phillips | M | 61 | - | |
| Ingrid Atteryd Heiman | F | 66 | - | |
| Hendrik-Jan Stoker | M | - |
University of Tilburg
| 3 years |
| Magnus Sjögren | M | 60 | - | |
| Els Boerhof | F | 54 |
University of Tilburg
| 5 years |
| Wietze Reehoorn | M | 62 |
University of Groningen
| 1 years |
| Herman Voortman | M | 61 |
University of Groningen
| 3 years |
| Pieter Oosthoek | M | 60 |
University of Groningen
| 3 years |
| Jaap den Engelsman | M | - |
University of Groningen
| 1 years |
| Patrick Claessen | M | - |
University of Tilburg
| 6 years |
| Imarus Johannes Adalarius van Lieshout | M | 55 |
University of Tilburg
| - |
| Jan Dunning | M | 64 |
University of Groningen
| 4 years |
| Magnus Sjoegren | M | - | - | |
| Arjan Lejour | M | - |
University of Tilburg
| 3 years |
| Atilla Aytekin | M | - |
University of Tilburg
| 4 years |
| Outi Lahdenpera | F | - | - | |
| Niek den Hollander | M | 50 |
University of Tilburg
| 6 years |
| Frans van der Horst | M | 64 |
University of Groningen
| 1 years |
| Jakob de Haan | M | - |
University of Groningen
| 3 years |
| Leo de Haan | M | - |
University of Tilburg
| 2 years |
| Steven Vette | M | 62 |
University of Groningen
| 4 years |
| Desiree Alberts | F | - |
University of Tilburg
| 5 years |
| Lienke van Balderen | F | - |
University of Groningen
| 6 years |
| Jan vrins | M | - |
University of Tilburg
| 6 years |
| Tjerk Huysinga | M | - |
University of Groningen
| 4 years |
| Marcel van Heesewijk | M | 63 |
University of Groningen
| 4 years |
| Reyer Zwiggelaar | M | - |
University of Groningen
| 4 years |
| Sipko Schat | M | 64 |
University of Groningen
| 3 years |
| Robert Verhoeven | M | - |
University of Tilburg
| 1 years |
| Rein Strijker | M | 67 |
University of Groningen
| 3 years |
| Bartout Gieben | M | - |
University of Groningen
| 7 years |
| Rob J. Frohn | M | 64 |
University of Groningen
| 1 years |
| Timo Mika Juhani Ahopelto | M | 49 |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | 5 years |
| Frank Claassen | M | 53 |
University of Tilburg
| 6 years |
| Annemiek M. Fentener van Vlissingen | F | 63 |
University of Groningen
| 4 years |
| Leendert van Reeuwijk | M | 58 |
University of Tilburg
| 4 years |
| Wouter Moerel | M | - |
University of Groningen
| 6 years |
| David Kerstens | M | - |
University of Groningen
| 5 years |
| Rob H. ten Heggeler | M | 59 |
University of Groningen
| 1 years |
| Wim Schoenmaker | M | - |
University of Groningen
| 3 years |
| Burkhard Blank | M | 69 | - | |
| Jurgen Stegmann | M | 63 |
University of Tilburg
| 1 years |
| Harry Laan | M | - |
University of Groningen
| 7 years |
| Dirkjan Masman | M | 73 |
University of Groningen
| 3 years |
| Ton Huls | M | - |
University of Groningen
| 6 years |
| Pamela Gertrude Boumeester | M | 65 |
University of Groningen
| 4 years |
| Harm J. Scherpbier | M | - |
University of Groningen
| 4 years |
| Charlotte Videbaek | M | 62 | - | |
| Willem Lucas Timmermans | M | 61 |
University of Groningen
| 4 years |
| Floris van Woerkom | M | 61 |
University of Tilburg
| 1 years |
| George Dessing | M | - |
University of Tilburg
| 2 years |
| Sander Odijk | M | 52 |
University of Tilburg
| 4 years |
| Hans Janssen | M | 57 |
University of Tilburg
| 4 years |
| Notermans Daniel | M | - |
University of Tilburg
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Netherlands | 47 | 63.51% |
| Finland | 25 | 33.78% |
| United States | 1 | 1.35% |
| Switzerland | 1 | 1.35% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Frans Gustaf Wuite
- Personal Network
